Download Files:
TAK1-IN-4
SKU
HY-122642-10 mg
Category Reference compound
Tags Inflammation/Immunology, MAP3K, MAPK/ERK Pathway
$380 – $620
Products Details
Product Description
– TAK1-IN-4 (Compound 14) is a TAK1 inhibitor[1].
Web ID
– HY-122642
Storage Temperature
– 4°C (Powder, protect from light)
Shipping
– Room Temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C18H17N3O3
References
– [1]Emily Derbyshire, et al. Novel inhibitors of transforming growth factor kinase and methods of use thereof. Patent US20180105500A1.
CAS Number
– 1570374-32-1
Molecular Weight
– 323.35
Compound Purity
– 99.47
SMILES
– O=C(C1=CC=CC(C(NC2=NC3=C(N2CCC)C=CC=C3)=O)=C1)O
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– DMSO : 83.33 mg/mL (ultrasonic)
Target
– MAP3K
Isoform
– MAP3K7/TAK1
Pathway
– MAPK/ERK Pathway
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.